Expert Review of Anticancer Therapy

Expert Review of Anticancer Therapy期刊基本信息

Expert Review of Anticancer Therapy
  • 简称:EXPERT REV ANTICANC
  • 大类:医学
  • 小类:肿瘤学
  • ISSN:1473-7140
  • IF值:2.571
  • 周期:Bimonthly
  • 是否SCI:SCIE
  • 是否OA:No
  • 出版地:ENGLAND
  • 年文章数:107
  • 审稿速度:偏慢,4-8周
  • 平均录用比例:容易
投稿咨询

官方网站:http://www.tandfonline.com/toc/iery20/current#.V48dKEz9cSQ

投稿网址:https://mc.manuscriptcentral.com/ert

PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1473-7140%5BISSN%5D

Expert Review of Anticancer Therapy中文简介

由Future Drugs出版。国际标准书号:1473-7140。对抗癌治疗的专家审查提供了专家评估和评论癌症护理的主要趋势,并强调了新的治疗和诊断方法的性能。覆盖范围包括肿瘤管理、新药、抗癌剂和化疗、生物疗法、癌症疫苗、治疗适应症、生物标志物和诊断以及治疗指南。所有的文章都要经过严格的同行评审,杂志对癌症治疗的决策做出了重要的贡献。

Expert Review of Anticancer Therapy英文简介

Published by Future-Drugs. ISSN: 1473-7140.Expert Review of Anticancer Therapy provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care.

国际期刊推选 论文翻润预审发表!

选择丰富服务快速通过率高一键快速领取私人专属发表方案!

* 请认真填写需求信息,学术顾问24小时内与您取得联系。